Systemic treatment in breast-cancer patients with brain metastasis

被引:37
|
作者
Arslan, Cagatay [1 ]
Dizdar, Omer [1 ]
Altundag, Kadri [1 ]
机构
[1] Hacettepe Univ, Inst Oncol, Dept Med Oncol, TR-0000 Ankara, Turkey
关键词
CENTRAL-NERVOUS-SYSTEM; PHASE-II TRIAL; DOSE INTRAVENOUS METHOTREXATE; TEMOZOLOMIDE; WEEKS; PROGNOSTIC-FACTORS; SOLID TUMORS; CEREBROSPINAL-FLUID; RANDOMIZED-TRIAL; I/II TRIAL; LEPTOMENINGEAL METASTASIS;
D O I
10.1517/14656561003702412
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Areas covered in this review: Standard therapy for brain metastasis is currently whole-brain radiotherapy. Other treatment modalities include surgery and radiosurgery in selected cases, corticosteroids, and systemic chemotherapy. Little progress has been made in chemotherapy for the treatment of brain metastases, partly because tumors develop brain metastases at a stage when they become totally chemoresistant. Nevertheless, new treatment choices have emerged considering cytotoxic and biological agents for the treatment of CNS metastases in patients with breast cancer. What the readers will gain: In this review, we aimed to review current and future treatment options in the systemic treatment of brain metastases of breast cancer. Take home message: Corticosteroids, anti-epileptic drugs, and radiotherapy remain the cornerstones of management. The efficacy of conventional cytotoxic chemotherapeutics is limited. Novel biologic agents, lapatinib being the most promising, are currently investigated in the treatment of brain metastases of breast cancer with promising results.
引用
收藏
页码:1089 / 1100
页数:12
相关论文
共 50 条
  • [1] Systemic Treatment for Brain Metastasis and Leptomeningeal Disease in Breast Cancer Patients
    Puri, Sushant
    Chaudhry, Amina
    Bayable, Asnakech
    Ganesh, Ashwin
    Daher, Ahmad
    Gadi, Vijayakrishna K.
    Maraka, Stefania
    [J]. CURRENT ONCOLOGY REPORTS, 2023, 25 (12) : 1419 - 1430
  • [2] Systemic Treatment for Brain Metastasis and Leptomeningeal Disease in Breast Cancer Patients
    Sushant Puri
    Amina Chaudhry
    Asnakech Bayable
    Ashwin Ganesh
    Ahmad Daher
    Vijayakrishna K. Gadi
    Stefania Maraka
    [J]. Current Oncology Reports, 2023, 25 : 1419 - 1430
  • [3] SUCCESSFUL TREATMENT OF BRAIN METASTASIS IN BREAST-CANCER PATIENTS BY CHEMOHORMONO-THERAPY
    MENDE, S
    STOETER, P
    REULEN, HJ
    [J]. ACTA NEUROCHIRURGICA, 1983, 68 (1-2) : 136 - 137
  • [4] Primary systemic treatment of breast-cancer brain metastases
    Bartsch, Rupert
    Preusser, Matthias
    [J]. LANCET ONCOLOGY, 2013, 14 (01): : 8 - 9
  • [5] SYSTEMIC TREATMENT OF BREAST-CANCER
    RICHARDS, MA
    [J]. JOURNAL OF THE ROYAL SOCIETY OF HEALTH, 1991, 111 (04): : 141 - 145
  • [6] SYSTEMIC TREATMENT OF BREAST-CANCER
    CARBONE, PP
    [J]. CANCER DETECTION AND PREVENTION, 1976, 1 (02): : 395 - 408
  • [7] TREATMENT OF BONE METASTASIS IN BREAST-CANCER
    HEIMPEL, H
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1987, 112 (07) : 286 - 286
  • [8] COMBINATION CHEMOTHERAPY OF BRAIN METASTASIS IN BREAST-CANCER
    ROSNER, D
    NEMOTO, T
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 405 - 405
  • [9] EFFECT OF BROMOCRIPTINE ON BRAIN METASTASIS IN BREAST-CANCER
    GRISOLI, F
    VINCENTELLI, F
    FOA, J
    LAVAIL, G
    SALAMON, G
    [J]. LANCET, 1981, 2 (8249): : 745 - 746
  • [10] ADJUVANT SYSTEMIC TREATMENT FOR BREAST-CANCER
    REIZENSTEIN, P
    [J]. LANCET, 1989, 1 (8640): : 728 - 728